发明名称 CANCER MONITORING AND THERAPEUTICS
摘要 Provided for are three novel isoenzyme variants of the human Hyaluronan Synthase gene, HAS 1 V a, HAS 1 Vb, and HAS 1 Vc. Also provided is a method for assessing disease, or susceptibility to disease, in a patient; in which a cell or sample of a cell population is mixed with at least one compound which specifically binds to HAS 1 Va, HAS 1 Vb, HAS 1 Vc or HAS2 isoenzyme or isoenzyme variant genomic mRNA transcript or products arising therefrom; and methods of treatment.
申请公布号 CA2441681(A1) 申请公布日期 2004.11.22
申请号 CA20032441681 申请日期 2003.09.25
申请人 THE GOVERNORS OF THE UNIVERSITY OF ALBERTA 发明人 ADAMIA, SOPHIA;PILARSKI, LINDA;BELCH, ANDREW;HAY, MARY;REIMAN, TONY
分类号 A61K31/496;A61K31/7088;A61K31/728;A61K38/16;A61K39/395;A61K45/00;A61K48/00;C12N9/10;C12N15/54;C12Q1/02;C12Q1/68;G01N33/53;(IPC1-7):C12N15/54;A61K31/708 主分类号 A61K31/496
代理机构 代理人
主权项
地址